Patent · US Active

Prohibitin as target for cancer therapy

US8658615B2 · kind B2 · utility

0Cited by

3References

25Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Krishnaraj Rajalingam · Berlin, DE
Thomas Rudel · Berlin, DE

Key dates

Filing date	Oct 18, 2011
Grant date	Feb 25, 2014
Priority date	—
Expiry date	Jan 18, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/10
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to pharmaceutical compositions comprising inhibitors of Prohibitin (PHB) for the prevention or/and treatment of hyperproliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.